| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.08 | 0.6 |